Science Explorer Interactive view Map
Company · Épalinges · Switzerland

Med Discovery (Switzerland)

med-discovery.comROR OpenAlex
Research works
18
▲ 68% vs 2013–17
Citations
587
31.7 per fractional work
Top-10% rate
12.2%
record average 16.5%
Open access
30%
world 28%

Not ranked overall: Med Discovery (Switzerland) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 1.15× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 6.62× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 4.77× its world share, 0 worksImmunology and Micro…Chemistry: 1.54× its world share, 0 worksChemistryEngineering: 0.10× its world share, 0 worksEngineeringMedicine: 2.35× its world share, 2 worksMedicineNursing: 11.13× its world share, 0 worksNursing1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Nursing, 11.1×. Every wedge is a field page.

Which research topics does Med Discovery (Switzerland) publish most on?

By volume in 2022–2025: CAR-T cell therapy research, Peptidase Inhibition and Analysis, Ubiquitin and proteasome pathways and Protein Degradation and Inhibitors.

CAR-T cell therapy resea…1CAR-T cell therapy research: 1 fractional worksPeptidase Inhibition and…0Peptidase Inhibition and Analysis: 0 fractional worksUbiquitin and proteasome…0Ubiquitin and proteasome pathways: 0 fractional worksProtein Degradation and Inhibitors: 0 fractional worksFood Chemistry and Fat Analysis: 0 fractional worksBiochemical Analysis and…0Biochemical Analysis and Sensing Techniques: 0 fractional worksGlycosylation and Glycoproteins Research: 0 fractional worksImmunotherapy and Immune Responses: 0 fractional worksCancer Research and Treatments: 0 fractional worksCarbohydrate Chemistry and Synthesis: 0 fractional works
OncologyMolecular BiologyFood ScienceNutrition and Dietetics3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CAR-T cell therapy research Oncology 1 works
  2. 2 Peptidase Inhibition and Analysis Oncology 0 works
  3. 3 Ubiquitin and proteasome pathways Molecular Biology 0 works
  4. 4 Protein Degradation and Inhibitors Molecular Biology 0 works
  5. 5 Food Chemistry and Fat Analysis Food Science 0 works
  6. 6 Biochemical Analysis and Sensing Techniques Nutrition and Dietetics 0 works
  7. 7 Glycosylation and Glycoproteins Research Molecular Biology 0 works
  8. 8 Immunotherapy and Immune Responses Immunology 0 works
  9. 9 Cancer Research and Treatments Biotechnology 0 works
  10. 10 Carbohydrate Chemistry and Synthesis Organic Chemistry 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available29.8%not open70.2%

World: 28% of research is openly available.

with international co-authors59.1%domestic only40.9%

World: 19% is written across borders.

How has Med Discovery (Switzerland)'s research output changed?

Output in 2018–2022 was 68% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Épalinges

All research institutions in Épalinges

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.